Quidel Corporation (QDEL) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.

Total Assets Chart for Quidel Corporation

Quidel Corporation (QDEL) total assets for FY2025 were USD 5.8B, a -10.2% change from FY2024. Quidel Corporation's total assets grew from USD 17.5M in 1985 to USD 5.8B in 2025 (32867.4% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 25.3%, 10-year CAGR of 30.4%, 20-year CAGR of 21.7%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$941.54M
Implied Share Price
$13.73
Enterprise Value
$3.70B
Revenue (TTM)
$2.67B
EBITDA
$484.60M
Profit Margin
-39.20%
Trailing P/E
—
Forward P/E
9.59
Price/Book (MRQ)
0.42
Price/Sales (TTM)
0.35
EV/EBITDA
22.78
EV/Revenue
1.38
Dividend Yield
—
Book Value
$25.99
Free Cash Flow (FY2025)
-$83.00M
Free Cash Flow Yield
-8.82%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.